News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
News Novavax secures full EU approval for COVID-19 vaccine Nuvaxo... In the first of a double dose of wins for US biotech Novavax, the company has been granted full marketing authorisation (MA) by the
News Janssen's quarterly schizophrenia drug approved in EU Company hopes new formulation will improve patient outcomes.
News Flagship joins three biotechs together to form Etcelera Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms from its portfolio.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
